Posted in | News | Business | Electronics

Optomec Announces Expansion of its Additive Manufacturing IP Portfolio

Optomec announced today that the Company’s Intellectual Property (IP) portfolio in the field of Additive Manufacturing grew to 35 patents with the addition of six new patents granted in 2012. These new patents cover inventions for the Company’s Aerosol Jet technology used for Printed Electronics. Optomec also announced it has received notices of allowance for additional patents which are expected to be granted in 2013.

The newly granted patents included three in the United States and three in Asia. Of particular note, Optomec received protection for its technologies that enable printing of high conductivity circuitry onto temperature sensitive plastic (low cost) substrates using laser curing techniques. Additionally, the company received patents in the area of printed passive structures (i.e.: resistors, antenna, etc); tilting of the head to enable printing on 3D surfaces; and high resolution printing for fine feature electronics.

Finally, Optomec received several patents protecting hardware enhancements that enable high throughput printing for high volume manufacturing applications. These include multiplexing strategies for key elements of the Aerosol Jet system, including the atomizer that serves as the input mechanism, and the focusing head that defines printed output.

Dave Ramahi, President/CEO of Optomec, stated, “Optomec’s growing patent portfolio is testimony to the unique and enabling nature of our underlying technology. These recent awards, combined with our broader IP portfolio, help ensure that our customers can enjoy a critical competitive advantage as they adopt our solutions for high volume manufacturing of their own products.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.